bioAllers® utilizes extensive scientific research and ongoing clinical studies to bring allergy sufferers allergen-specific products that not only relieve the annoying symptoms of an allergic reaction, but also help desensitize allergy sufferers against future allergic episodes.

With bioAllers® liquids and new, quick-dissolving tablets, the body is gently and gradually exposed to allergens in small doses, allowing their natural defense to adapt to the allergen and no longer react to it. In addition, each formula contains a combination of key homeopathic ingredients for the relief of allergy symptoms such as sneezing, congestion, headache, itchy and watery eyes and breathing difficulties. The result is a product line that works with the body naturally to bring about relief in a fast and safe manner. For years, bioAllers® has been widely recognized as the nations #1 natural allergy brand.

• Advanced formulations that include the most common allergens
• Help build up a resistance against future allergy episodes
• Made in accordance with FDA Drug Manufacturing standards

Controlled Clinical Studies Published in Peer Reviewed Journals

(1) Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. Morag A Taylor, David Reilly, Robert H Llewellyn-Jones,Charles McSharry, Tom C Aitchison, British Medical Journal BMJ 2000;321:471-476 ( 19 August )
Abstract Objective: To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series. Design: Randomised, double blind, placebo controlled, parallel group, multicentre study. Setting: Four general practices and a hospital ear, nose, and throat outpatient department. Participants: 51 patients with perennial allergic rhinitis. Intervention: Random assignment to an oral 30c homoeopathic preparation of principal inhalant allergen or to placebo. Main outcome measures: Changes from baseline in nasal inspiratory peak flow and symptom visual analogue scale score over third and fourth weeks after randomisation.

Results: Fifty patients completed the study. The homoeopathy group had a significant objective improvement in nasal airflow compared with the placebo group. Both groups reported improvement in symptoms, with patients taking homoeopathy reporting more improvement in all but one of the centres, which had more patients with aggravations. On average no significant difference between the groups was seen on visual analogue scale scores. Initial aggravations of rhinitis symptoms were more common with homoeopathy than placebo.

Addition of these results to those of three previous trials showed a mean symptom reduction on visual analogue scores of 28% for homoeopathy compared with 3% for placebo (95% confidence interval). Conclusion: The objective results reinforce earlier evidence that homoeopathic dilutions differ from placebo.

(2) Is Evidence for Homoeopathy Reproducible? D. Reilly, M. Taylor, N. Beattie, et al., Lancet, December 10, 1994, 344:1601-6.
This study successfully reproduced evidence from two previous double-blinded trials all of which used the same model of homeopathic immunotherapy in inhalant allergy. In this third study, 9 of 11 patients on homeopathic treatment improved compared to only 5 of 13 patients on placebo. The researchers concluded that either homeopathic medicines work or controlled studies don't. Their work has again be recently replicated and is submitted for publication.

(3) Is Homeopathy a Placebo Response? Controlled Trial of Homeopathic Potency with Pollen in Hayfever as Model, D. Reilly, M. Taylor, C. McSherry, Lancet, October 18, 1986, 881-86.
The double-blind study compared a high dilution homeopathic preparation of grass pollens against a placebo in 144 patients with active hay fever. The study method considered pollen counts, aggravation in symptoms and use of antihistamines and concluded that patients using homeopathy showed greater improvement in symptoms than those on placebo, and that this difference was reflected in a significantly reduced need for antihistamines among the homeopathically treated group. The results confirmed those of the pilot study and demonstrate that homeopathic potencies show effects distinct from those of the placebo